Rubiscolin-6, a δ opioid peptide derived from spinach Rubisco, has anxiolytic effect via activating σ1 and dopamine D1 receptors

Abstract Rubiscolin-6 (Tyr-Pro-Leu-Asp-Leu-Phe) is a δ opioid peptide derived from the large subunit of spinach d -ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco). We previously reported that rubiscolin-6 had an analgesic effect and stimulated memory consolidation. Here we show that intraperitoneally (i.p.) or orally administered rubiscolin-6 has an anxiolytic effect at a dose of 10 mg/kg or 100 mg/kg, respectively, in the elevated plus-maze test in mice. The anxiolytic effects of rubscolin-6 after i.p. (10 mg/kg) and oral (100 mg/kg) administration were blocked by a δ opioid receptor antagonist, naltrindole (1 mg/kg, s.c.), suggesting that the anxiolytic activity of rubiscolin-6 is mediated by δ opioid receptor. The anxiolytic effect of rubiscolin-6 (10 mg/kg, i.p.) was also blocked by a dopamine D 1 antagonist, SCH23390 (30 μg/kg, i.p.), but not by a dopamine D 2 antagonist, raclopride (15 μg/kg, i.p.). The anxiolytic effect of rubiscolin-6 (10 mg/kg, i.p.) was blocked by σ 1 receptor antagonist, BMY14802 (0.5 mg/kg, i.p.) or BD1047 (10 mg/kg, i.p.). Taken together, the anxiolytic effect of rubiscolin-6 is mediated by σ 1 and dopamine D 1 receptors downstream of δ opioid receptor.

[1]  Tetsuya Kobayashi,et al.  σ1 Receptor subtype is involved in the relief of behavioral despair in the mouse forced swimming test , 1996 .

[2]  H. Meisel.  Biochemical properties of regulatory peptides derived from milk proteins. , 1997, Biopolymers.

[3]  M. Kasuga,et al.  Anxiolytic effect of motilin and reversal with GM-109, a motilin antagonist, in mice , 1998, Peptides.

[4]  M. Takahashi,et al.  Delta opioid peptides derived from plant proteins. , 2003, Current pharmaceutical design.

[5]  Kenneth M. Johnson,et al.  Classification and nomenclature of phencyclidine and sigma receptor sites , 1987, Trends in Neurosciences.

[6]  V. Ganapathy,et al.  Cocaine-sensitive sigma-receptor and its interaction with steroid hormones in the human placental syncytiotrophoblast and in choriocarcinoma cells. , 1995, Endocrinology.

[7]  T. Kameyama,et al.  Role of (+)-SKF-10,047-sensitive sub-population of sigma 1 receptors in amelioration of conditioned fear stress in rats: association with mesolimbic dopaminergic systems. , 1997, European journal of pharmacology.

[8]  J. Kamei,et al.  Potential anxiolytic and antidepressant-like activities of SNC80, a selective delta-opioid agonist, in behavioral models in rodents. , 2004, Journal of pharmacological sciences.

[9]  T. Kameyama,et al.  Stimulation of δ1- and δ2-opioid receptors produces amnesia in mice , 1997 .

[10]  K. Nakasho,et al.  Relationship between Sigma‐like site and progesterone‐binding site of adult male rat liver microsomes , 1994, Hepatology.

[11]  J. Thompson,et al.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.

[12]  F E Bloom,et al.  Central catecholamine neuron systems: anatomy and physiology of the dopamine systems. , 1978, Annual review of neuroscience.

[13]  M. Yoshikawa,et al.  Opioid peptides derived from wheat gluten: Their isolation and characterization , 1992, FEBS letters.

[14]  A. Lipkowski,et al.  Rubiscolin, a δ selective opioid peptide derived from plant Rubisco , 2001 .

[15]  J. Costentin,et al.  Involvement of corticostriatal glutamatergic terminals in striatal dopamine release elicited by stimulation of δ‐opioid receptors , 2004, The European journal of neuroscience.

[16]  T. Kameyama,et al.  Effects of endomorphins-1 and -2, endogenous mu-opioid receptor agonists, on spontaneous alternation performance in mice. , 2000, European journal of pharmacology.

[17]  Youngnam Kang,et al.  Molecular basis underlying GABAA responses in rat mesencephalic trigeminal neurons , 2002, Neuroreport.

[18]  F. C. Hartman,et al.  Structure, Function, Regulation, and Assembly of D-Ribulose-1,5-Bisphosphate Carboxylase/Oxygenase , 1994 .

[19]  Stanley J. Watson,et al.  Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications , 1995, Trends in Neurosciences.

[20]  M. Kasuga,et al.  Endomorphins have orexigenic and anxiolytic activities in mice , 1998, Neuroreport.

[21]  N. Koshikawa,et al.  Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens , 2005, Neuroscience.

[22]  T. Kikuchi,et al.  3,4-dihydro-2(1H)-quinolinone as a novel antidepressant drug: synthesis and pharmacology of 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-3,4- dihydro-5-methoxy-2(1H)-quinolinone and its derivatives. , 2000, Journal of medicinal chemistry.

[23]  A. Dierich,et al.  Mice deficient for δ- and μ-opioid receptors exhibit opposing alterations of emotional responses , 2000, Nature Genetics.

[24]  A. Asakawa,et al.  Increased circulating cholecystokinin contributes to anorexia and anxiety behavior in mice overexpressing pancreatic polypeptide , 2007, Regulatory Peptides.

[25]  Teruo Hayashi,et al.  σ-1 Receptor Ligands , 2004 .

[26]  A. Privat,et al.  Modulation by neurosteroids of the in vivo (+)‐[3H]SKF‐10,047 binding to σ1 receptors in the mouse forebrain , 1996, Journal of neuroscience research.

[27]  M. Kasuga,et al.  Neuropeptide Y Produces Anxiety Via Y2-Type Receptors , 1998, Peptides.

[28]  T. Kameyama,et al.  Endomorphins 1 and 2, endogenous mu-opioid receptor agonists, impair passive avoidance learning in mice. , 2001, European journal of pharmacology.

[29]  Liping Chen,et al.  Structure–activity relationship of rubiscolins as δ opioid peptides , 2003, Peptides.

[30]  C. Nemeroff,et al.  Neuropeptides, Dopamine, and Schizophrenia a , 1988, Annals of the New York Academy of Sciences.

[31]  F. M. Freeman,et al.  Inhibition of passive-avoidance memory formation in the day-old chick by the opioid cytochrophin-4. , 2000, Learning & memory.

[32]  T. Kameyama,et al.  Beneficial Effects of Acute and Repeated Administrations of σ Receptor Agonists on Behavioral Despair in Mice Exposed to Tail Suspension , 1998, Pharmacology Biochemistry and Behavior.

[33]  Y. Kawamura,et al.  Effect of rubiscolin, a δ opioid peptide derived from Rubisco, on memory consolidation , 2003, Peptides.